Loading insider details...
Latest Form 4 (Jun 11, 2026): Exercise/Conversion of 1,429 AXSM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 1,429 | n/a |
| Jun 9, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,721 | n/a |
| Jan 3, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 6,231 | $50.0K |
| Sep 5, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 9,127 | $82.1K |
| Jun 10, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 3,166 | n/a |
| Feb 25, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,494 | n/a |
| Sep 11, 2024 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 11,016 | $40.4K |
| Jun 11, 2024 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 5,799 | n/a |
| Feb 29, 2024 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,519 | n/a |
| Jun 6, 2023 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 5,681 | n/a |